Publication

Constructing Lipoparticles Capable of Endothelial Cell-Derived Exosome-Mediated Delivery of Anti-miR-33a-5p to Cultured Macrophages

Downloadable Content

Persistent URL
Last modified
  • 06/17/2025
Type of Material
Authors
    Jing Echesabal-Chen, Clemson UniversityKun Huang, Clemson UniversityLucia Vojtech, University of Washington, SeattleOOlanrewaju Oladosu, Clemson UniversityIkechukwu Esobi, Clemson UniversityRakesh Sachdeva, Clemson UniversityNaren Vyavahare, Clemson UniversityHanjoong Jo, Emory UniversityAlexis Stamatikos, Clemson University
Language
  • English
Date
  • 2023-07-01
Publisher
  • MDPI
Publication Version
Copyright Statement
  • © 2023 by the authors.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 45
Issue
  • 7
Start Page
  • 5631
End Page
  • 5644
Grant/Funding Information
  • This work was supported in part by an SC BioCRAFT Pilot Project award (NIH/NIGMS) (P30GM131959) and Hatch Project (USDA-NIFA) (project no. SC-1700577; accession no. 1021291). Jing Echesabal-Chen was partially supported by a CU FELLOWS R-Initiatives grant from Clemson University Division of Research.
Abstract
  • Atherosclerosis is driven by intimal arterial macrophages accumulating cholesterol. Atherosclerosis also predominantly occurs in areas consisting of proinflammatory arterial endothelial cells. At time of writing, there are no available clinical treatments that precisely remove excess cholesterol from lipid-laden intimal arterial macrophages. Delivery of anti-miR-33a-5p to macrophages has been shown to increase apoAI-mediated cholesterol efflux via ABCA1 upregulation but delivering transgenes to intimal arterial macrophages is challenging due to endothelial cell barrier integrity. In this study, we aimed to test whether lipoparticles targeting proinflammatory endothelial cells can participate in endothelial cell-derived exosome exploitation to facilitate exosome-mediated transgene delivery to macrophages. We constructed lipoparticles that precisely target the proinflammatory endothelium and contain a plasmid that expresses XMOTIF-tagged anti-miR-33a-5p (LP-pXMoAntimiR33a5p), as XMOTIF-tagged small RNA demonstrates the capacity to be selectively shuttled into exosomes. The cultured cells used in our study were immortalized mouse aortic endothelial cells (iMAECs) and RAW 264.7 macrophages. From our results, we observed a significant decrease in miR-33a-5p expression in macrophages treated with exosomes released basolaterally by LPS-challenged iMAECs incubated with LP-pXMoAntimiR33a5p when compared to control macrophages. This decrease in miR-33a-5p expression in the treated macrophages caused ABCA1 upregulation as determined by a significant increase in ABCA1 protein expression in the treated macrophages when compared to the macrophage control group. The increase in ABCA1 protein also simulated ABCA1-dependent cholesterol efflux in treated macrophages—as we observed a significant increase in apoAI-mediated cholesterol efflux—when compared to the control group of macrophages. Based on these findings, strategies that involve combining proinflammatory-targeting lipoparticles and exploitation of endothelial cell-derived exosomes appear to be promising approaches for delivering atheroprotective transgenes to lipid-laden arterial intimal macrophages.
Author Notes
Keywords
Research Categories
  • Engineering, Biomedical
  • Biology, Molecular
  • Health Sciences, Obstetrics and Gynecology
  • Chemistry, Biochemistry
  • Agriculture, Animal Culture and Nutrition
  • Chemistry, General

Tools

Relations

In Collection:

Items